GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BGLAF) » Definitions » Price-to-Free-Cash-Flow

BioGaia AB (BioGaia AB) Price-to-Free-Cash-Flow : 41.17 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Price-to-Free-Cash-Flow?

As of today (2024-05-21), BioGaia AB's share price is $12.31. BioGaia AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30. Hence, BioGaia AB's Price-to-Free-Cash-Flow Ratio for today is 41.17.

The historical rank and industry rank for BioGaia AB's Price-to-Free-Cash-Flow or its related term are showing as below:

BGLAF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.69   Med: 42.99   Max: 167.36
Current: 41.18

During the past 13 years, BioGaia AB's highest Price-to-Free-Cash-Flow Ratio was 167.36. The lowest was 16.69. And the median was 42.99.

BGLAF's Price-to-Free-Cash-Flow is ranked worse than
68.5% of 508 companies
in the Drug Manufacturers industry
Industry Median: 23.31 vs BGLAF: 41.18

BioGaia AB's Free Cash Flow per Share for the three months ended in Mar. 2024 was $0.04. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.30.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of BioGaia AB was 3.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 17.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 17.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 13.90% per year.

During the past 13 years, BioGaia AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 180.10% per year. The lowest was -33.70% per year. And the median was 22.25% per year.


BioGaia AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for BioGaia AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Price-to-Free-Cash-Flow Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.19 46.74 48.55 28.05 27.09

BioGaia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.87 37.61 28.34 27.09 39.29

Competitive Comparison of BioGaia AB's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Price-to-Free-Cash-Flow falls into.



BioGaia AB Price-to-Free-Cash-Flow Calculation

BioGaia AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=12.31/0.299
=41.17

BioGaia AB's Share Price of today is $12.31.
BioGaia AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.30.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

BioGaia AB  (OTCPK:BGLAF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


BioGaia AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB (BioGaia AB) Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.